- Supported exchanges /
- TWO /
- 6785.TWO
Alar Pharmaceuticals Inc. (6785 TWO) stock market data APIs
Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. It is developing ALA-1000, which is in Phase II clinical trials for the treatment of opioid use disorder; ALA-1300 and ALA-2000, which is in pre-clinical stage for opioid use disorder; ALA-4000 which is in pre-clinical stage for treatment of Parkinson's disease; and ALA-3000, which is in pre-clinical stage for treating treatment-resistant depression. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.
Alar Pharmaceuticals Inc. Financial Data Overview
| 167.5 | |
| 171.5 | |
| - | |
| 171.5 | |
| 166 | |
| 162-462.4497 | |
| 11 189 M | |
| 22.9138 | |
| 66 800 K | |
| 469 M | |
| 0.0088 | |
| 0.065 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Alar Pharmaceuticals Inc. Fundamental Data is available in our Financial Data APIs
- Net Revenue 469 M
- EBITDA 384 M
- Earnings Per Share 7.31
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Alar Pharmaceuticals Inc. Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get Alar Pharmaceuticals Inc. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
